Stock futures dipped on Thursday as investors weighed President Trump’s 90-day tariff reprieve for select countries, which ...

DexCom DXCM underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing ...

The S&P 500 Index ($SPX) (SPY) today is down -3.05%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -2.52%, and the ...

The S&P 500 Index ($SPX) (SPY) today is down -2.50%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -2.05%, and the ...

Dexcom (Nadsaq:DXCM) announced today that the FDA cleared its G7 15-day continuous glucose monitoring (CGM) system.

The San Diego-based medical device company stated that the Dexcom G7 15 Day has an overall Mean Absolute Relative Difference (MARD) of 8.0%, showcasing its precision in glucose level readings. The ...

Mizuho analyst Anthony Petrone initiated coverage of DexCom (DXCM) with an Outperform rating and $85 price target The firm cites its positive ...

DexCom Inc. closed 52.68% below its 52-week high of $141.25, which the company reached on April 11th.

U.S. stocks were lower, with the Dow Jones index dipping over 800 points on Thursday. Pricesmart reported quarterly earnings ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the FDA has cleared the Dexcom G7 15 Day ...

Shares traded 8.5% higher at $72.55. The company, which focuses on glucose biosensing--which measures glucose levels in wearers--said that the Food and Drug Administration has cleared the Dexcom G7 15 ...

Investing.com -- Morgan Stanley flagged the weakest U.S. cruise demand in three years following fresh channel checks, prompting earnings and price target cuts across the sector. The brokerage said its ...